Collaborative R&D agreement for Azymetric platform for development of bi- specific antibody therapeutic candidatesCollaborative R&d Agreement • February 9th, 2022
Contract Type FiledFebruary 9th, 2022Zymeworks has earned a milestone payment from Merck (known as MSD outside the US and Canada) achieved under the companies’ 2014 research and license agreement.
Collaborative R&D agreement for Azymetric platform for development of bi- specific antibody therapeutic candidatesCollaborative R&d Agreement • September 27th, 2020
Contract Type FiledSeptember 27th, 2020Zymeworks has earned a milestone payment from Merck (known as MSD outside the US and Canada) achieved under the companies’ 2014 research and license agreement.